VPHC Holdings — ProFund VP Health Care
All 60 reported holdings of ProFund VP Health Care (VPHC) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Company | 14.44% | $5.07M |
| Johnson & Johnson | 9.31% | $3.26M |
| Abbvie, Inc. | 6.77% | $2.37M |
| Unitedhealth Group, Inc. | 5.75% | $2.02M |
| Merck & Company, Inc. | 4.83% | $1.69M |
| Amgen, Inc. | 2.98% | $1.04M |
| Thermo Fisher Scientific, Inc. | 2.84% | $994.70K |
| Abbott Laboratories | 2.41% | $843.88K |
| Gilead Sciences, Inc. | 2.39% | $837.38K |
| Intuitive Surgical, Inc. | 2.14% | $752.01K |
| Pfizer, Inc. | 2.09% | $732.75K |
| Cvs Health Corp. | 2.01% | $704.70K |
| Vertex Pharmaceuticals, Inc. | 1.92% | $673.07K |
| Danaher Corp. | 1.83% | $640.58K |
| Bristol-Myers Squibb Company | 1.79% | $628.23K |
| Stryker Corp. | 1.65% | $579.94K |
| Medtronic PLC | 1.53% | $536.27K |
| Mckesson Corp. | 1.38% | $485.10K |
| Elevance Health, Inc. | 1.28% | $448.22K |
| Cigna Group (the) | 1.11% | $389.26K |
| Boston Scientific Corp. | 0.97% | $338.71K |
| Regeneron Pharmaceuticals, Inc. | 0.95% | $332.35K |
| Hca Healthcare, Inc. | 0.92% | $323.22K |
| Cardinal Health, Inc. | 0.85% | $296.95K |
| Cencora, Inc. | 0.84% | $294.02K |
| Edwards Lifesciences Corp. | 0.79% | $278.07K |
| Humana, Inc. | 0.73% | $254.62K |
| Becton Dickinson & Company | 0.63% | $222.61K |
| Idexx Laboratories, Inc. | 0.63% | $221.63K |
| Agilent Technologies, Inc. | 0.57% | $200.44K |
| Waters Corp. | 0.56% | $196.52K |
| Iqvia Holdings, Inc. | 0.49% | $172.16K |
| Biogen, Inc. | 0.49% | $170.26K |
| Zoetis, Inc. | 0.46% | $160.82K |
| Centene Corp. | 0.46% | $160.80K |
| Ge Healthcare Technologies, Inc. | 0.44% | $155.48K |
| Resmed, Inc. | 0.43% | $150.84K |
| Veeva Systems, Inc. | 0.41% | $142.33K |
| Dexcom, Inc. | 0.40% | $138.74K |
| Mettler-Toledo International, Inc. | 0.39% | $137.97K |
| West Pharmaceutical Services, Inc. | 0.39% | $135.34K |
| Moderna, Inc. | 0.38% | $132.01K |
| Quest Diagnostics, Inc. | 0.36% | $125.26K |
| Labcorp Holdings, Inc. | 0.35% | $122.64K |
| Steris PLC | 0.31% | $110.34K |
| Incyte Corp. | 0.29% | $101.57K |
| Viatris, Inc. | 0.28% | $98.74K |
| Zimmer Biomet Holdings, Inc. | 0.25% | $88.93K |
| Cooper Companies, Inc. (the) | 0.21% | $74.72K |
| Revvity, Inc. | 0.19% | $66.31K |
| Solventum Corp. | 0.17% | $60.64K |
| Align Technology, Inc. | 0.17% | $60.04K |
| Bio-Techne Corp. | 0.17% | $59.06K |
| Baxter International, Inc. | 0.17% | $58.78K |
| Charles River Laboratories International, Inc. | 0.17% | $58.29K |
| Insulet Corp. | 0.16% | $56.33K |
| Henry Schein, Inc. | 0.12% | $43.18K |
| Universal Health Services, Inc. | 0.12% | $42.38K |
| Davita, Inc. | 0.11% | $38.04K |
VPHC overview: performance, fees, allocation and SEC filings